 BBA Consulting -  Independent Consulting

Experienced Clinical Operations & Project Management leadership & support for the Pharmaceutical and Biotechnology drug development industry.

Senior Clinical Operations Consultant

Kronos Bio

Senior Clinical Trial Manager - Senior Clinical Operations Consultant

Golden Gate University

Support the Alumni Association’s governing body with the mission of fostering beneficial connections among alumni, students and faculty

http://www.ggu.edu/alumni/board-of-directors/

GGU Alumni Board of Directors

Private Investor

Cryptocurrency, Real Estate Investor, and Disruptive/Innovative Stocks.

Founder & CEO - BBA Capital Investments

IGM Biosciences, Inc.

Project contributions supported the advancement of imvotamab (IGM-2323) Phase 1/2 autoimmune diseases (Systemic lupus erythematosus and rheumatoid arthritis).

Clinical Program Manager - Senior Clinical Operations Consultant

Jazz Pharmaceuticals

Project contributions supported Vyxeos®, Rylaze™, Zepzelca™ collaborative (CO) and Investigator-Sponsored Research (ISR) clinical trials.

Zogenix, Inc.

Project contributions supported FINTEPLA® (approved 25-June-2020) for the treatment of Dravet Syndrome (DS), Lennox-Gastaut Syndrome (LGS) (approved 28-Mar-2022), and advancement of CDKL5 Deficiency Disorder (CDD).

Zogenix, Inc. (Nasdaq: ZGNX) was acquired by UCB (Euronext: UCB) on 19January2022 for $1.9 Billion USD.

Apollomics

Project contributions supported advancement of APL-101, a novel, orally administered, selective c-MET inhibitor.

Clinical Trial Manager

Gilead Sciences

Project contributions supported approval of BIKTARVY® 07-February-2018

Senior Clinical Trials Management Associate - Antivirals (HIV-ClinOps)

Project contributions supported approval of ODEFSEY® 01-March-2016 and DESCOVY® 04-April-2016

Clinical Trials Management Associate - Antivirals (HIV-ClinOps)

Project contributions supported approval of GENVOYA® 22-October-2015

CPA - Antivirals (HIV-ClinOps)

Genentech

Project contributions supported approval of TECENTRIQ® 18-MAY-2016

Taplio

Bobby Asem, MBA's Linkedin Analytics

Want to drive more opportunities from LinkedIn?

Taplio

.css-1jgreyo{background-image:linear-gradient(284deg, rgba(39,43,72,1) 0%, rgba(33,47,183,1) 100%);color:transparent;-webkit-background-clip:text;background-clip:text;}Bobby Asem, MBA's Linkedin Analytics

Want to drive more opportunities from LinkedIn?

Bobby Asem, MBA's Linkedin Analytics